These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
4. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation. Lobashevsky AL; Senkbeil RW; Shoaf J; Mink C; Rowe C; Lobashevsky ES; Burke R; Hudson S; Deierhoi MH; Thomas JM Clin Transplant; 2000 Dec; 14(6):533-42. PubMed ID: 11127305 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Kerman RH; Susskind B; Buyse I; Pryzbylowski P; Ruth J; Warnell S; Gruber SA; Katz S; Van Buren CT; Kahan BD Transplantation; 1999 Dec; 68(12):1855-8. PubMed ID: 10628764 [TBL] [Abstract][Full Text] [Related]
6. The flow cytometric crossmatch and early renal transplant loss. Mahoney RJ; Ault KA; Given SR; Adams RJ; Breggia AC; Paris PA; Palomaki GE; Hitchcox SA; White BW; Himmelfarb J Transplantation; 1990 Mar; 49(3):527-35. PubMed ID: 2138366 [TBL] [Abstract][Full Text] [Related]
7. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization. Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237 [TBL] [Abstract][Full Text] [Related]
8. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients. Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764 [TBL] [Abstract][Full Text] [Related]
9. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. Lobashevsky AL; Senkbeil RW; Shoaf JL; Stephenson AK; Skelton SB; Burke RM; Deierhoi MH; Thomas JM Hum Immunol; 2002 May; 63(5):364-74. PubMed ID: 11975980 [TBL] [Abstract][Full Text] [Related]
10. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques. Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411 [TBL] [Abstract][Full Text] [Related]
11. Presensitization and HLA match influence the predictive power of pretransplant serum IgA and IgA-anti-Fab autoantibodies in kidney graft recipients. Süsal C; Wiesel M; Schönemann C; Groth J; Carl S; Staehler G; May G; Opelz G Transplant Proc; 1997; 29(1-2):1444-6. PubMed ID: 9123373 [No Abstract] [Full Text] [Related]
12. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study. Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689 [TBL] [Abstract][Full Text] [Related]
13. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity as prognostic indicators of kidney graft survival. Süsal C; Dörr C; Groth J; May G; Opelz G Transpl Int; 1994; 7 Suppl 1():S586-9. PubMed ID: 11271315 [TBL] [Abstract][Full Text] [Related]
14. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss. Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719 [TBL] [Abstract][Full Text] [Related]
15. Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation. Vaidya S; Cooper TY; Avandsalehi J; Barnes T; Brooks K; Hymel P; Noor M; Sellers R; Thomas A; Stewart D; Daller J; Fish JC; Gugliuzza KK; Bray RA Transplantation; 2001 Feb; 71(3):422-8. PubMed ID: 11233905 [TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between IgG T-lymphocyte flow cytometric crossmatches with primary renal allograft outcome. Evans PR; Lane AC; Lambert CM; Reynolds WM; Wilson PJ; Harris KR; Slapak M; Lee HA; Smith JL Transpl Int; 1992; 5 Suppl 1():S609-12. PubMed ID: 14621889 [TBL] [Abstract][Full Text] [Related]
17. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch. Limaye S; O'Kelly P; Harmon G; O'Neill D; Dorman AM; Walshe J; Donohoe J; Little D; Conlon PJ; Keogan MT Transplantation; 2009 Apr; 87(7):1052-6. PubMed ID: 19352127 [TBL] [Abstract][Full Text] [Related]
18. Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival. Arnold ML; Bach C; Heinemann FM; Horn PA; Ziemann M; Lachmann N; Mühlbacher A; Dick A; Ender A; Thammanichanond D; Schaub S; Hönger G; Fischer GF; Mytilineos J; Hallensleben M; Hitzler WE; Seidl C; Spriewald BM Int J Immunogenet; 2018 Jun; 45(3):95-101. PubMed ID: 29575597 [TBL] [Abstract][Full Text] [Related]